UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis

Molecular Biology of the Cell

Volumn 23, Issue 1, 2012, Pages 59-70

  Chua, Jaime ^a   Loughlin, Elizabeth A ^a   Gaur, Naseem A ^b   SenBanerjee, Sucharita ^b   Jacob, Vinitha ^a   Monson, Christopher ^a   Kent, Brandon ^a   Oranu, Amanke ^b   Ding, Yuanying ^b   Ukomadu, Chinweike ^b   Sadler, Kirsten C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A2; CYCLIN DEPENDENT KINASE 2; CYCLIN E; MORPHOLINO OLIGONUCLEOTIDE; PROTEIN; SERINE; UBIQUITIN LIKE CONTAINING PHD AND RING FINGER DOMAIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; GASTRULATION; GENE MUTATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WILD TYPE; ZEBRA FISH;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CONSENSUS SEQUENCE; CYCLIN A2; CYCLIN-DEPENDENT KINASE 2; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; GASTRULA; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; TRANS-ACTIVATORS; ZEBRAFISH; ZEBRAFISH PROTEINS;

DANIO RERIO; MAMMALIA; VERTEBRATA;

EID: 84855416370     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-06-0487     Document Type: Article

References (72)

1. Abbady AQ, Bronner C, Bathami K, Muller CD, Jeanblanc M, Mathieu E, Klein JP, Candolfi E, Mousli M (2005). TCR pathway involves ICBP90 gene down-regulation via E2F binding sites. Biochem Pharmacol 70, 570-579. (Pubitemid 40978547)
2. Abbady AQ, Bronner C, Trotzier MA, Hopfner R, Bathami K, Muller CD, Jeanblanc M, Mousli M (2003). ICBP90 expression is downregulated in apoptosis-induced Jurkat cells. Ann NY Acad Sci 1010, 300-303. (Pubitemid 38264993)
3. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N (2004). Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA 101, 12792-12797. (Pubitemid 39167537)
4. Anderson RM et al. (2009). Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration. Dev Biol 334, 213-223.
5. Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, Ishikawa H, Saya H (2004). Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1- dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells 9, 131-142. (Pubitemid 38312957)
6. Bernstein BE et al. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326.
7. Bonapace IM, Latella L, Papait R, Nicassio F, Sacco A, Muto M, Crescenzi M, Di Fiore PP (2002). Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry. J Cell Biol 157, 909-914. (Pubitemid 34839765)
8. Bostick M, Kim JK, Esteve PO, Clark A, Pradhan S, Jacobsen SE (2007). UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317, 1760-1764. (Pubitemid 47461842)
9. Bronner C, Achour M, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB (2007). The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future. Pharmacol Ther 115, 419-434. (Pubitemid 47362377)
10. Brunet J, Pfaff AW, Abidi A, Unoki M, Nakamura Y, Guinard M, Klein JP, Candolfi E, Mousli M (2008). Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation. Cell Microbiol 10, 908-920. (Pubitemid 351386946)
11. Citterio E, Papait R, Nicassio F, Vecchi M, Gomiero P, Mantovani R, Di Fiore PP, Bonapace IM (2004). Np95 is a histone-binding protein endowed with ubiquitin ligase activity. Mol Cell Biol 24, 2526-2535. (Pubitemid 38326006)
12. Crnogorac-Jurcevic T et al. (2005). Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 129, 1454-1463. (Pubitemid 41597388)
13. Fang Z, Xing F, Bronner C, Teng Z, Guo Z (2009). ICBP90 mediates the ERK1/2 signaling to regulate the proliferation of Jurkat T cells. Cell Immunol 257, 80-87.
14. Feng S et al. (2010). Conservation and divergence of methylation patterning in plants and animals. Proc Natl Acad Sci USA 107, 8689-8694.
15. Fujimori A, Matsuda Y, Takemoto Y, Hashimoto Y, Kubo E, Araki R, Fukumura R, Mita K, Tatsumi K, Muto M (1998). Cloning and mapping of Np95 gene which encodes a novel nuclear protein associated with cell proliferation. Mamm Genome 9, 1032-1035. (Pubitemid 29030909)
16. Hashimoto H, Horton JR, Zhang X, Bostick M, Jacobsen SE, Cheng X (2008). The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 455, 826-829.
17. Higashi H, Suzuki-Takahashi I, Taya Y, Segawa K, Nishimura S, Kitagawa M (1995). Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro. Biochem Biophys Res Commun 216, 520-525.
18. Hopfner R, Mousli M, Jeltsch JM, Voulgaris A, Lutz Y, Marin C, Bellocq JP, Oudet P, Bronner C (2000). ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIα expression. Cancer Res 60, 121-128. (Pubitemid 30058741)
19. Hopfner R, Mousli M, Oudet P, Bronner C (2002). Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression. Anticancer Res 22, 3165-3170. (Pubitemid 36070088)
20. Jeanblanc M, Mousli M, Hopfner R, Bathami K, Martinet N, Abbady AQ, Siffert JC, Mathieu E, Muller CD, Bronner C (2005). The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle. Oncogene 24, 7337-7345. (Pubitemid 41622238)
21. Jenkins Y et al. (2005). Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mol Biol Cell 16, 5621-5629. (Pubitemid 41752212)
22. Johnson LM, Bostick M, Zhang X, Kraft E, Henderson I, Callis J, Jacobsen SE (2007). The SRA methyl-cytosine-binding domain links DNA and histone methylation. Curr Biol 17, 379-384. (Pubitemid 46241885)
23. Kaldis P, Sutton A, Solomon MJ (1996). The Cdk-activating kinase (CAK) from budding yeast. Cell 86, 553-564. (Pubitemid 26299487)
24. Kane DA, Kimmel CB (1993). The zebrafish midblastula transition. Development 119, 447-456. (Pubitemid 23293187)
25. Karagianni P, Amazit L, Qin J, Wong J (2008). ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol Cell Biol 28, 705-717.
26. Kawakami K (2007). Tol2: a versatile gene transfer vector in vertebrates. Genome Biol 8 (suppl 1), S7.
27. Kim JK, Esteve PO, Jacobsen SE, Pradhan S (2009). UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res 37, 493-505.
28. Kitagawa M et al. (1996). The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 15, 7060-7069. (Pubitemid 27023276)
29. Knoblich JA, Sauer K, Jones L, Richardson H, Saint R, Lehner CF (1994). Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell 77, 107-120. (Pubitemid 24184692)
30. Krek W, Xu G, Livingston DM (1995). Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83, 1149-1158. (Pubitemid 26007806)
31. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, Parant JM, Yost HJ, Kanki JP, Chien CB (2007). The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn 236, 3088-3099. (Pubitemid 350175006)
32. Li Y, Mori T, Hata H, Homma Y, Kochi H (2004). NIRF induces G1 arrest and associates with Cdk2. Biochem Biophys Res Commun 319, 464-468. (Pubitemid 38725969)
33. Lindeman LC, Reiner AH, Mathavan S, Alestrom P, Collas P (2010a). Tiling histone H3 lysine 4 and 27 methylation in zebrafish using high-density microarrays. PLoS One 5, e15651.
34. Lindeman LC, Winata CL, Aanes H, Mathavan S, Alestrom P, Collas P (2010b). Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos. Int J Dev Biol 54, 803-813.
35. Malumbres M, Barbacid M (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9, 153-166.
36. Meehan RR, Dunican DS, Ruzov A, Pennings S (2005). Epigenetic silencing in embryogenesis. Exp Cell Res 309, 241-249. (Pubitemid 41317349)
37. Meilinger D, Fellinger K, Bultmann S, Rothbauer U, Bonapace IM, Klinkert WE, Spada F, Leonhardt H (2009). Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells. EMBO Rep 10, 1259-1264.
38. Miura M, Watanabe H, Sasaki T, Tatsumi K, Muto M (2001). Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci. Exp Cell Res 263, 202-208. (Pubitemid 32989094)
39. Mousli M, Hopfner R, Abbady AQ, Monte D, Jeanblanc M, Oudet P, Louis B, Bronner C (2003). ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br J Cancer 89, 120-127. (Pubitemid 36897947)
40. Mudbhary R, Sadler KC (2011). Epigenetics, development, and cancer: zebrafish make their ARK. Birth Defects Res C Embryo Today 93, 194-203.
41. Muto M, Kanari Y, Kubo E, Takabe T, Kurihara T, Fujimori A, Tatsumi K (2002). Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J Biol Chem 277, 34549-34555.
42. Newport J, Kirschner M (1982a). A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage. Cell 30, 675-686. (Pubitemid 13204657)
43. Newport J, Kirschner M (1982b). A major developmental transition in early Xenopus embryos: II. control of the onset of transcription. Cell 30, 687-696. (Pubitemid 13204658)
44. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M (1995). Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15, 2612-2624.
45. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G (1992). Cyclin A is required at two points in the human cell cycle. EMBO J 11, 961-971.
46. Papait R et al. (2008). The PHD domain of Np95 (mUHRF1) is involved in large-scale reorganization of pericentromeric heterochromatin. Mol Biol Cell 19, 3554-3563.
47. Rajakumara E et al. (2011). PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. Mol Cell 43, 275-284.
48. Resnitzky D, Hengst L, Reed SI (1995). Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell Biol 15, 4347-4352.
49. Resnitzky D, Reed SI (1995). Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol 15, 3463-3469.
50. Robu ME, Larson JD, Nasevicius A, Beiraghi S, Brenner C, Farber SA, Ekker SC (2007). p53 activation by knockdown technologies. PLoS Genet 3, e78.
51. Rottach A, Frauer C, Pichler G, Bonapace IM, Spada F, Leonhardt H (2010). The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Res 38, 1796-1804.
52. Sadler KC, Krahn KN, Gaur NA, Ukomadu C (2007). Liver growth in the embryo and during liver regeneration in zebrafish requires the cell cycle regulator, uhrf1. Proc Natl Acad Sci USA 104, 1570-1575. (Pubitemid 46214631)
53. Schier AF (2007). The maternal-zygotic transition: death and birth of RNAs. Science 316, 406-407.
54. Schier AF, Talbot WS (2005). Molecular genetics of axis formation in zebrafish. Annu Rev Genet 39, 561-613. (Pubitemid 43011127)
55. Sharif J et al. (2007). The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450, 908-912. (Pubitemid 350231331)
56. Su TT, Stumpff J (2004). Promiscuity rules? The dispensability of cyclin E and Cdk2. Sci STKE 2004, pe11.
57. Tadros W, Lipshitz HD (2009). The maternal-to-zygotic transition: a play in two acts. Development 136, 3033-3042.
58. Takeda DY, Wohlschlegel JA, Dutta A (2001). A bipartite substrate recognition motif for cyclin-dependent kinases. J Biol Chem 276, 1993-1997. (Pubitemid 32109678)
59. Tien AL, Senbanerjee S, Kulkarni A, Mudbhary R, Goudreau B, Ganesan S, Sadler KC, Ukomadu C (2011). UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis. Biochem J 435, 175-185.
60. Tittle RK, Sze R, Ng A, Nuckels RJ, Swartz ME, Anderson RM, Bosch J, Stainier DY, Eberhart JK, Gross JM (2011). Uhrf1 and Dnmt1 are required for development and maintenance of the zebrafish lens. Dev Biol 350, 50-63.
61. Trotzier MA, Bronner C, Bathami K, Mathieu E, Abbady AQ, Jeanblanc M, Muller CD, Rochette-Egly C, Mousli M (2004). Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIα expression. Biochem Biophys Res Commun 319, 590-595. (Pubitemid 38725987)
62. Uemura T, Kubo E, Kanari Y, Ikemura T, Tatsumi K, Muto M (2000). Temporal and spatial localization of novel nuclear protein NP95 in mitotic and meiotic cells. Cell Struct Funct 25, 149-159.
63. Ukomadu C, Dutta A (2003a). Inhibition of cdk2 activating phosphorylation by mevastatin. J Biol Chem 278, 4840-4846. (Pubitemid 36800989)
64. Ukomadu C, Dutta A (2003b). p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. J Biol Chem 278, 43586-43594. (Pubitemid 37345984)
65. Unoki M, Bronner C, Mousli M (2008). A concern regarding the current confusion with the human homolog of mouse Np95, ICBP90/UHRF1. Radiat Res 169, 240-244. (Pubitemid 351295082)
66. Unoki M, Nishidate T, Nakamura Y (2004). ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 23, 7601-7610. (Pubitemid 39424918)
67. Vastenhouw NL, Zhang Y, Woods IG, Imam F, Regev A, Liu XS, Rinn J, Schier AF (2010). Chromatin signature of embryonic pluripotency is established during genome activation. Nature 464, 922-926.
68. Villefranc JA, Amigo J, Lawson ND (2007). Gateway compatible vectors for analysis of gene function in the zebrafish. Dev Dyn 236, 3077-3087. (Pubitemid 350175005)
69. Wang C et al. (2011). Structural basis for site-specific reading of unmodified R2 of histone H3 tail by UHRF1 PHD finger. Cell Res 21, 1379-1382.
70. Wohlschlegel JA, Dwyer BT, Takeda DY, Dutta A (2001). Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases. Mol Cell Biol 21, 4868-4874. (Pubitemid 32656385)
71. Woo HR, Pontes O, Pikaard CS, Richards EJ (2007). VIM1, a methylcytosine-binding protein required for centromeric heterochromatinization. Genes Dev 21, 267-277.
72. Zindy F, Lamas E, Chenivesse X, Sobczak J, Wang J, Fesquet D, Henglein B, Brechot C (1992). Cyclin A is required in S phase in normal epithelial cells. Biochem Biophys Res Commun 182, 1144-1154.